Publication Date
In 2025 | 0 |
Since 2024 | 2 |
Descriptor
Cancer | 2 |
Medical Research | 2 |
Bayesian Statistics | 1 |
Feasibility Studies | 1 |
Medical Care Evaluation | 1 |
Medical Services | 1 |
Meta Analysis | 1 |
Oncology | 1 |
Program Implementation | 1 |
Reaction Time | 1 |
Research Methodology | 1 |
More ▼ |
Source
Research Synthesis Methods | 2 |
Author
Alessandro Gasparini | 1 |
Alex J. Sutton | 1 |
Bruno Laviolle | 1 |
Clara Locher | 1 |
Laura Caquelin | 1 |
Lucas Poulain | 1 |
Michael J. Crowther | 1 |
Moreno Ursino | 1 |
Neil Hawkins | 1 |
Nicola J. Cooper | 1 |
Pauline Badra | 1 |
More ▼ |
Publication Type
Journal Articles | 2 |
Reports - Research | 2 |
Information Analyses | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Suzanne C. Freeman; Alex J. Sutton; Nicola J. Cooper; Alessandro Gasparini; Michael J. Crowther; Neil Hawkins – Research Synthesis Methods, 2024
Background: Traditionally, meta-analysis of time-to-event outcomes reports a single pooled hazard ratio assuming proportional hazards (PH). For health technology assessment evaluations, hazard ratios are frequently extrapolated across a lifetime horizon. However, when treatment effects vary over time, an assumption of PH is not always valid. The…
Descriptors: Cancer, Medical Research, Bayesian Statistics, Meta Analysis
Laura Caquelin; Pauline Badra; Lucas Poulain; Bruno Laviolle; Moreno Ursino; Clara Locher – Research Synthesis Methods, 2024
This study aimed to assess the feasibility of applying two recent phase I meta-analyses methods to protein kinase inhibitors (PKIs) developed in oncology and to identify situations where these methods could be both feasible and useful. This ancillary study used data from a systematic review conducted to identify dose-finding studies for PKIs. PKIs…
Descriptors: Oncology, Cancer, Medical Care Evaluation, Medical Research